Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 935Lymphoid 196Myeloid 111Plasma cell 108Classical hematology 63Gastrointestinal 25Breast 23Genitourinary 21Thoracic 18Dermatologic 18CNS 18Sarcoma 16Head & Neck 12Gynecologic 9Other 6Endocrine 3Other neoplasm 1NET 1

Conditions

Precancerous Conditions 138Lymphoma 35Leukemia 34Multiple Myeloma 33Leukemia, Lymphocytic, Chronic, B-Cell 32Neoplasms, Plasma Cell 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Monoclonal Gammopathy of Undetermined Significance 29Lymphoma, Non-Hodgkin 29Lymphoma, Mantle-Cell 29Lymphoma, Large-Cell, Immunoblastic 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 29Burkitt Lymphoma 28Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, B-Cell, Marginal Zone 27Hodgkin Disease 27Myelodysplastic Syndromes 26Immunoglobulin Light-chain Amyloidosis 26Myeloproliferative Disorders 25Lymphoma, T-Cell, Cutaneous 25Immunoblastic Lymphadenopathy 25Waldenstrom Macroglobulinemia 24Lymphoma, Large-Cell, Anaplastic 24Leukemia, Myeloid, Acute 24Uterine Cervical Neoplasms 22Primary Myelofibrosis 22Leukemia, Large Granular Lymphocytic 22Leukemia, Hairy Cell 22Thrombocythemia, Essential 21

Interventions

Patient Reported Outcome Measures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hematologic Neoplasms × Other neoplasm × Clear all
NCT04663100 2023-12-04

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

University of Tennessee

Phase NA Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡